BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6445604)

  • 21. Human equivalent doses of platelet inhibitors and experimental atherosclerosis.
    Mittal SR; Mathur AK; Tandon R
    Int J Cardiol; 1990 May; 27(2):275-6. PubMed ID: 2365516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet adhesion to rabbit aorta by sulphinpyrazone and acetylsalicylic acid.
    Essien EM; Mustard JF
    Atherosclerosis; 1977 May; 27(1):89-95. PubMed ID: 856231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative suppression of platelet adherence to small-diameter polytetrafluoroethylene (PTFE) grafts.
    Fujitani RM; Nordestgaard AG; Marcus CS; Wilson SE
    J Surg Res; 1988 Apr; 44(4):455-60. PubMed ID: 3361888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
    Weiss HJ
    Am Heart J; 1976 Jul; 92(1):86-102. PubMed ID: 785989
    [No Abstract]   [Full Text] [Related]  

  • 25. Time of low-dose acetylsalicylic acid administration influences in vivo platelet function and thrombus formation following arteriotomy and intimectomy; an experimental study in small arteries of rabbits.
    Salemark L; Wieslander JB; Dougan P; Arnljots B
    Microsurgery; 1990; 11(3):209-14. PubMed ID: 2215187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of controlled local acetylsalicylic acid release on in vitro platelet adhesion to vascular grafts.
    Hall JD; Rittgers SE; Schmidt SP
    J Biomater Appl; 1994 Apr; 8(4):361-84. PubMed ID: 8064590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin decreases platelet uptake on Dacron vascular grafts in baboons.
    Mackey WC; Connolly RJ; Callow AD; Keough EM; Ramberg-Laskaris K; McCullough JL; O'Donnell TF; Melaragno A; Valeri CR; Weiblen B
    Ann Surg; 1984 Jul; 200(1):93-9. PubMed ID: 6233945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of platelets in thrombotic and vascular disease.
    Schafer AI; Handin RI
    Prog Cardiovasc Dis; 1979; 22(1):31-52. PubMed ID: 379914
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of sulfinpyrazone on platelet deposition on Dacron vascular grafts in man.
    Stratton JR; Ritchie JL
    Am Heart J; 1985 Mar; 109(3 Pt 1):453-7. PubMed ID: 3156474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
    Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
    Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
    de Gaetano G; Cerletti C; Bertelè V
    Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
    [No Abstract]   [Full Text] [Related]  

  • 35. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
    Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
    Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A specific thromboxane receptor blocking drug, AH23848, reduces platelet deposition on vascular grafts in man.
    Lane IF; Lumley P; Michael MF; Peters AM; McCollum CN
    Thromb Haemost; 1990 Nov; 64(3):369-73. PubMed ID: 2151407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
    Müller TH; Su CA; Weisenberger H; Brickl R; Nehmiz G; Eisert WG
    Br J Clin Pharmacol; 1990 Aug; 30(2):179-86. PubMed ID: 2206782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction.
    Müller TH
    Neurology; 2001; 57(5 Suppl 2):S8-S11. PubMed ID: 11552048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient ischemic attacks due to increased platelet aggregation and adhesiveness. Ultrastructural and functional correlation.
    al-Mefty O; Marano G; Raiaraman S; Nugent GR; Rodman N
    J Neurosurg; 1979 Apr; 50(4):449-53. PubMed ID: 422999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.